Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25 TTM Selling/general/admin expenses 272 M273 M277 M308 M 1.13 B Research & development 240 M252 M229 M239 M 960 M Operating income 209 M245 M227 M202 M 883 M Non-Operating Income, Total -52 M15 M-7 M176 M 132 M Interest expense, net of interest capitalized 24 M24 M25 M26 M 99 M Non-Operating Income, excl. Interest Expenses -13 M-16 M-16 M-16 M -61 M Unusual income/expense -39 M31 M9 M192 M 193 M Pretax income 157 M260 M220 M378 M 1.01 B Equity in earnings ———— — Taxes 23 M53 M70 M44 M 190 M Non-controlling/minority interest ———— — After tax other income/expense -8 M4 M-9 M0 -13 M Net income before discontinued operations 134 M207 M150 M334 M 825 M Discontinued operations ———— — Net income 134 M207 M150 M334 M 825 M Dilution adjustment ———— — Preferred dividends ———— — Diluted net income available to common stockholders 134 M207 M150 M334 M 825 M Basic earnings per share (Basic EPS) 0.881.370.982.17 5.4 Diluted earnings per share (Diluted EPS) 0.871.350.982.16 5.36 Average basic shares outstanding 153 M151 M153 M155 M — Diluted shares outstanding 154 M153 M154 M156 M — EBITDA 295 M351 M294 M268 M 1.21 B EBIT 209 M245 M227 M202 M 883 M Cost of revenue 370 M389 M351 M400 M 1.51 B Other cost of goods sold ———— — Depreciation & amortization (cash flow) 86 M106 M67 M66 M 325 M